Spirodiketopiperazine-based CCR5 antagonists: Improvement of their pharmacokinetic profiles.

Publication

Citation
Nishizawa R, Nishiyama T, Hisaichi K, Hirai K, Habashita H, Takaoka Y, Tada H, Sagawa K, Shibayama S, Maeda K, Mitsuya H, Nakai H, Fukushima D, Toda M.: Spirodiketopiperazine-based CCR5 antagonists: Improvement of their pharmacokinetic profiles. Bioorg Med Chem Lett, Volume 20 (2), 2010
Authors
Fukushima D, Habashita H, Hirai K, Hisaichi K, Maeda K, Mitsuya H, Nakai H, Nishiyama T, Nishizawa R, Sagawa K, Shibayama S, Tada H, Takaoka Y, Toda M.
Journal
Bioorg Med Chem Lett
Year
2010
PubMed
20005712
Machine-readable
REST APIRDF
Palacky University Olomouc

Palacky University Olomouc

Faculty of Science

Department of Physical Chemistry

tř. 17. listopadu 1192/12

771 46 Olomouc

Czech Republic

How to cite?

Juračka J., Šrejber M., Melíková M., Bazgier V., Berka K.: MolMeDB: Molecules on Membranes Database. Database, Volume 2019, 2019, baz078, https://doi.org/10.1093/database/baz078

Follow us

FacebookGithub

Financial Support

  • MolMeDB interoperability with UniProt and SwissLipids – MEYS Czech-Swiss project ELIXIR-IMPACT 8K0208 (2026–2028)
ELIXIRGAČRUP Olomouc
Spirodiketopiperazine-based CCR5 antagonists: Improvement of their pharmacokinetic profiles. | MolMeDB